Daudt H M L, van Mossel C, Dennis D L, Leitz L, Watson H C, Tanliao J J
Clinical Research, BC Cancer Agency-Vancouver Island Centre, Victoria, BC. ; Centre for Patient and Family Supportive Care Research, BC Cancer Agency-Vancouver Island Centre, Victoria, BC.
Faculty of Human and Social Development, University of Victoria, Victoria, BC. ; Professional Practice Nursing, BC Cancer Agency-Vancouver Island Centre, Victoria, BC.
Curr Oncol. 2014 Jun;21(3):e466-79. doi: 10.3747/co.21.1781.
Health agencies across the world have echoed the recommendation of the U.S. Institute of Medicine (iom) that survivorship care plans (scps) should be provided to patients upon completion of treatment. To date, reviews of scps have been limited to the United States. The present review offers an expanded scope and describes how scps are being designed, delivered, and evaluated in various countries.
We collected scps from Canada, the United States, Europe, the United Kingdom, Australia, and New Zealand. We selected for analysis the scps for which we could obtain the actual scp, information about the delivery approach, and evaluation data. We conducted a content analysis and compared the scps with the iom guidelines.
Of 47 scps initially identified, 16 were analyzed. The scps incorporated several of the iom's guidelines, but many did not include psychosocial services, identification of a key point of contact, genetic testing, and financial concerns. The model of delivery instituted by the U.K. National Cancer Survivorship Initiative stands out because of its unique approach that initiates care planning at diagnosis and stratifies patients into a follow-up program based on self-management capacities.
There is considerable variation in the approach to delivery and the extent to which scps follow the original recommendations from the iom. We discuss the implications of this review for future care-planning programs and prospective research. A holistic approach to care that goes beyond the iom recommendations and that incorporates care planning from the point of diagnosis to beyond completion of treatment might improve people's experience of cancer care.
世界各地的卫生机构都响应了美国医学研究所(IOM)的建议,即应在治疗结束后为患者提供生存护理计划(SCP)。迄今为止,对SCP的审查仅限于美国。本综述扩大了范围,描述了SCP在各个国家的设计、提供和评估方式。
我们收集了来自加拿大、美国、欧洲、英国、澳大利亚和新西兰的SCP。我们选择了能够获取实际SCP、提供方式信息和评估数据的SCP进行分析。我们进行了内容分析,并将SCP与IOM指南进行了比较。
在最初确定的47个SCP中,有16个进行了分析。这些SCP纳入了IOM的一些指南,但许多没有包括心理社会服务、关键联系人的确定、基因检测和财务问题。英国国家癌症生存倡议组织制定的提供模式因其独特的方法脱颖而出,该方法在诊断时启动护理计划,并根据自我管理能力将患者分层纳入后续计划。
SCP的提供方式以及SCP遵循IOM原始建议的程度存在很大差异。我们讨论了本综述对未来护理计划项目和前瞻性研究的影响。一种超越IOM建议、从诊断点到治疗结束后都纳入护理计划的整体护理方法可能会改善人们的癌症护理体验。